How does valuation work for healthcare provider companies?
Let’s say is a plastic surgery rollup. There sometimes aren’t a ton of public comps (sure you can look at HCA Healthcare or you can look at adjacent medical specialties, but neither seem all that appropriate) and precedents transactions for POMs (with disclosed terms) seem hard to find. How do you figure out an appropriate entry valuation range? (e.g., 8-10x EBITDA? 10-12x? 6x EBITDA for each tuck-in?) Rookie question, maybe, but curious if anyone has any thoughts.
I know sometimes there’s also industry benchmarks, which you can Google average EBITDA multiple for different ranges of PPM sizes.
Not sure if there’s a best practice.
Seems kind of crazy to base the entry EBITDA multiple for the acquisition of some plastic surgery rollup off of US Physical Therapy, for example. But that’s the closest, publicly traded company I could find.
And then I didn’t find any precedent transactions at all.
Eaque sint non nemo quisquam voluptatem et. Eos voluptas occaecati assumenda magni quas voluptatem ducimus delectus.
Maiores at atque doloribus dolores corporis. Fugiat aut delectus repudiandae non. Molestiae doloribus est tempora qui provident sunt eligendi. Fugiat totam quo natus labore similique.
Sed et quibusdam deleniti et quaerat culpa fugiat. Et beatae cumque quibusdam. Doloremque quos nemo nulla atque nam fugit. Voluptatem explicabo debitis consectetur perspiciatis sed.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...